Pneumonia is a public health concern that is especially important at the 2 ends of the age spectrum. For children, pneumonia is the most common cause of death worldwide and of hospitalization in the US. Pneumonia rates plummet in early childhood and remain low for decades, until they begin rising around the fifth decade and escalate ever after. For older Americans, pneumonia confers a significantly higher risk of death compared to all other common causes of hospitalization, and half of all infectious disease hospitalizations and deaths are due to pneumonia. There is little known about the naturally acquired protection against pneumonia in most older children and young adults.
We aim to elucidate this trough between the peaks of pneumonia susceptibility, to better define the immune mechanisms preventing pneumonia during late childhood and much of adulthood. We posit that heterotypic immunity, adaptive immune responses to related but not identical organisms, drives lung defense for most human-microbe interactions in the lung. For bacterial pneumonia, we propose that lung resident memory CD4+ T cells with polyfunctional Th17 phenotype are determinative, enhancing the antibacterial activities of resident alveolar macrophages and recruited neutrophils to more effectively eliminate pathogens in the deep lung. We have developed mouse models of infection-elicited heterotypic immunity against pneumococcus in the lungs, which will empower mechanistic investigations of these defenses. We will complement these studies with the first ever examinations of antibacterial responses by CD4+ T cells from human lung tissue. To test our central hypothesis that lung resident memory Th17 cells provide heterotypic immune defense against bacterial pneumonia, we will pursue 3 specific aims: (1) we will determine whether heterotypic immunity improves lung responses to bacteria via IL- 17 enhancement of phagocyte function, using mouse models of infection-elicited heterotypic protection and deletion or blockade of IL-17 signaling; (2) we will determine whether lungs contain specialized resident memory cells that drive local heterotypic antibacterial protection, using mouse models and ex vivo analyses of cells collected from fresh human lungs to investigate functional activities of resident memory CD4+ T cells; and (3) we will test whether lung heterotypic protection against pneumonia is prolonged by repeated stimulation and whether that protection declines during aging, using both mouse models and human lung patient samples. Elucidating these mechanisms protecting the lung from infection will be critical for guiding future efforts to identify subjects developing susceptibility, to counter susceptibilit, to strategize vaccine design, and to develop new therapies based on stimulating antibacterial activities from lung-resident CD4+ T cells.

Public Health Relevance

Pneumonia represents a major public health concern that is particularly prominent in children and in the elderly. Here we propose that this age-dependent disparity in lung host defense is attributable to the presence and function of resident memory CD4+ T cells, which are guided by prior exposures to related but not identical bacteria. By elucidating the immunological properties that confer protection between the 2 ends of the age spectrum, we aim to identify novel targets for clinical intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI115053-02
Application #
9089868
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Davidson, Wendy F
Project Start
2015-07-01
Project End
2019-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Boston University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
Smith, N Ms; Wasserman, G A; Coleman, F T et al. (2018) Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia. Mucosal Immunol 11:220-235
Hartmann, Nadine; McMurtrey, Curtis; Sorensen, Michelle L et al. (2018) Riboflavin Metabolism Variation among Clinical Isolates of Streptococcus pneumoniae Results in Differential Activation of Mucosal-associated Invariant T Cells. Am J Respir Cell Mol Biol 58:767-776
Mizgerd, Joseph P (2018) Inflammation and Pneumonia: Why Are Some More Susceptible than Others? Clin Chest Med 39:669-676
Quinton, Lee J; Walkey, Allan J; Mizgerd, Joseph P (2018) Integrative Physiology of Pneumonia. Physiol Rev 98:1417-1464
Mizgerd, Joseph P (2017) Pathogenesis of severe pneumonia: advances and knowledge gaps. Curr Opin Pulm Med 23:193-197
Wasserman, Gregory A; Szymaniak, Aleksander D; Hinds, Anne C et al. (2017) Expression of Piwi protein MIWI2 defines a distinct population of multiciliated cells. J Clin Invest 127:3866-3876
Coleman, Fadie T; Blahna, Matthew T; Kamata, Hirofumi et al. (2017) Capacity of Pneumococci to Activate Macrophage Nuclear Factor ?B: Influence on Necroptosis and Pneumonia Severity. J Infect Dis 216:425-435
Kozlowski, Elyse; Wasserman, Gregory A; Morgan, Marcos et al. (2017) The RNA uridyltransferase Zcchc6 is expressed in macrophages and impacts innate immune responses. PLoS One 12:e0179797
Traber, Katrina E; Symer, Elise M; Allen, Eri et al. (2017) Myeloid-epithelial cross talk coordinates synthesis of the tissue-protective cytokine leukemia inhibitory factor during pneumonia. Am J Physiol Lung Cell Mol Physiol 313:L548-L558
Kamata, Hirofumi; Yamamoto, Kazuko; Wasserman, Gregory A et al. (2016) Epithelial Cell-Derived Secreted and Transmembrane 1a Signals to Activated Neutrophils during Pneumococcal Pneumonia. Am J Respir Cell Mol Biol 55:407-18